Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes

The Health Improvement Network UK primary care database was used to identify a cohort of 38 077 individuals aged 50–84 years with a first prescription of low-dose acetylsalicylic acid (ASA; 75–300 mg/day) for secondary prevention of cardiovascular or cerebrovascular events during 2000–2007. From thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cea Soriano, Lucía, Rodríguez, Luis A. García
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2010
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140176/
https://www.ncbi.nlm.nih.gov/pubmed/21811460
http://dx.doi.org/10.3389/fphar.2010.00126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140176/
https://www.ncbi.nlm.nih.gov/pubmed/21811460
http://dx.doi.org/10.3389/fphar.2010.00126

Ejemplares similares